Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (104) 104
female (64) 64
oncology (53) 53
breast neoplasms - drug therapy (26) 26
medicine, research & experimental (25) 25
male (19) 19
middle aged (19) 19
treatment outcome (18) 18
adult (17) 17
antineoplastic agents - therapeutic use (16) 16
chemotherapy (16) 16
aged (15) 15
breast neoplasms - pathology (15) 15
prognosis (15) 15
retrospective studies (15) 15
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
antibodies, monoclonal, humanized (12) 12
breast cancer (11) 11
cancer (11) 11
index medicus (11) 11
medicine & public health (11) 11
trastuzumab (11) 11
antineoplastic agents - administration & dosage (10) 10
surgery (10) 10
breast neoplasms - metabolism (9) 9
neoplasm staging (9) 9
risk factors (9) 9
therapy (9) 9
aged, 80 and over (8) 8
antibodies, monoclonal - therapeutic use (8) 8
neoplasm metastasis (8) 8
obstetrics & gynecology (8) 8
radiotherapy (8) 8
respiratory system (8) 8
survival (8) 8
clinical trials as topic (7) 7
disease-free survival (7) 7
lung neoplasms - drug therapy (7) 7
models, biological (7) 7
adenocarcinoma - drug therapy (6) 6
lung neoplasms - pathology (6) 6
neoplasm recurrence, local (6) 6
time factors (6) 6
young adult (6) 6
adenocarcinoma - pathology (5) 5
adolescent (5) 5
antineoplastic agents - pharmacology (5) 5
bone neoplasms - secondary (5) 5
breast neoplasms - genetics (5) 5
breast neoplasms - therapy (5) 5
carcinoma, non-small-cell lung - drug therapy (5) 5
chemokine cxcl12 (5) 5
chemotherapy, adjuvant (5) 5
combined modality therapy (5) 5
drug resistance, neoplasm (5) 5
drug therapy (5) 5
expression (5) 5
gefitinib (5) 5
hematology (5) 5
paclitaxel - administration & dosage (5) 5
radiology, nuclear medicine & medical imaging (5) 5
receptor, epidermal growth factor - metabolism (5) 5
survival analysis (5) 5
turkey (5) 5
antineoplastic agents - adverse effects (4) 4
breast neoplasms - diagnosis (4) 4
breast neoplasms - mortality (4) 4
breast-cancer (4) 4
carcinoma (4) 4
carcinoma, non-small-cell lung - pathology (4) 4
care and treatment (4) 4
chemotherapy, adjuvant - methods (4) 4
diphosphonates - therapeutic use (4) 4
drug administration schedule (4) 4
endometrial cancer (4) 4
follow-up studies (4) 4
management (4) 4
medicine, general & internal (4) 4
phase-iii trial (4) 4
postmenopause (4) 4
receptors, estrogen - metabolism (4) 4
recurrence (4) 4
risk (4) 4
signal transduction (4) 4
thyroid cancer (4) 4
trial (4) 4
adenocarcinoma - surgery (3) 3
analysis (3) 3
animals (3) 3
antibodies, monoclonal - administration & dosage (3) 3
antibodies, monoclonal - pharmacology (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
bacterial infections - complications (3) 3
benzamides (3) 3
bone density - drug effects (3) 3
bone neoplasms - drug therapy (3) 3
brain neoplasms - secondary (3) 3
breast neoplasms - enzymology (3) 3
breast neoplasms - surgery (3) 3
calcinosis - etiology (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
by Mok, Tony and Mok, Tony S K and Wu, Yilong and Wu, Yi-Long and Kudaba, Iveta and Kowalski, Dariusz M and Kowalski, Dariusz and Cho, Byoung Chul and Turna, Hande and Turna, Hande Z and Castro, Hugo and Castro, Gilberto and Srimuninnimit, Vichien and Laktionov, Konstantin and Laktionov, Konstantin K and Bondarenko, Igor and Kubota, Kaoru and Lubiniecki, Gregory M and Zhang, Jin and Zhang, Li and Zhang, Xin and Kush, Debra and Lopes, Valeria and Lopes, Gilberto and Adamchuk, Grigory and Ahn, Myung-Ju and Alexandru, Aurelia and Altundag, Ozden and Alyasova, Anna and Andrusenko, Orest and Aoe, Keisuke and Araujo, Antonio and Aren, Osvaldo and Arrieta Rodriguez, Oscar and Ativitavas, Touch and Avendano, Oscar and Barata, Fernando and Barrios, Carlos Henrique and Beato, Carlos and Bergstrom, Per and Betticher, Daniel and Bolotina, Larisa and Botha, Michiel and Buddu, Sayeuri and Caglevic, Christian and Cardona, Andres and Cay Senler, Filiz and Cerny, Carlos Alexandre Sydow and Cesas, Alvydas and Chan, Gee-Chen and Chang, Jianhua and Chen, Xi and Chen, Gongyan and Cheng, Ying and Cheng, Susanna and Cherciu, Nelly and Chiu, Chao-Hua and Cicenas, Saulius and Ciurescu, Daniel and Cohen, Graham and Costa, Marcos Andre and Danchaivijitr, Pongwut and De Angelis, Flavia and de Azevedo, Sergio Jobim and Dediu, Mircea and Deliverski, Tsvetan and De Marchi, Pedro Rafael Martins and de The Bustamante Valles, Flor and Ding, Zhenyu and Doganov, Boyan and Dreosti, Lydia and Duarte, Ricardo and Edusma-Dy, Regina and Emelyanov, Sergey and Erman, Mustafa and Fan, Yun and Fein, Luis and Feng, Jifeng and Fenton, David and Fernandes, Gustavo and Ferreira, Carlos and Franke, Fabio Andre and Freitas, Helano and Fujisaka, Yasuhito and Galindo, Hector and Galvez, Christina and Ganea, Doina and Gil, Nuno and Girotto, Gustavo and Goker, Erdem and Goksel, Tuncay and Gomez Aubin, Gonzalo and Gomez Wolff, Luis and Griph, Hakan and Gumus, Mahmut and Hall, Jacqueline and Hart, Gregory and Havel, Libor and He, Yong and He, Jianxing and ... and KEYNOTE-042 Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10183, pp. 1819 - 1830
First-line pembrolizumab monotherapy improves overall and progression-free survival in patients with untreated metastatic non-small-cell lung cancer with a... 
MEDICINE, GENERAL & INTERNAL | CARBOPLATIN | GEFITINIB | BEVACIZUMAB | CRIZOTINIB | NIVOLUMAB | PACLITAXEL | Genes, erbB-1 - drug effects | Lung Neoplasms - drug therapy | Translocation, Genetic | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Lung Neoplasms - metabolism | Middle Aged | Far East - epidemiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Anaplastic Lymphoma Kinase - genetics | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Lung Neoplasms - secondary | Female | Carcinoma, Non-Small-Cell Lung - pathology | Anaplastic Lymphoma Kinase - drug effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Genes, erbB-1 - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Disease-Free Survival | B7-H1 Antigen - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm Metastasis - pathology | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Chemotherapy | Metastasis | Lung cancer, Non-small cell | Cancer | Slopes | Lung cancer | Oncology | Kinases | Cancer therapies | Metastases | Pembrolizumab | Randomization | Motivation | Platinum | Risk assessment | Population | Translocation | Cell survival | Life expectancy | Epidermal growth factor receptors | Hyperthyroidism | Histology | Hypothyroidism | Survival | Patients | Medical centres | Life span | Interactive systems | PD-L1 protein | Men | Ligands | Tumors | Apoptosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Posttransplant Malignancies in Adult Renal and Hepatic Transplant Patients
by Rahatli, Samed and Ayvazoglu Soy, Ebru H and Altundag, Ozden and Moray, Gokhan and Haberal, Mehmet
Transplantation, ISSN 0041-1337, 07/2018, Volume 102 Suppl 7S-1, pp. S225 - S225
INTRODUCTIONThe risk of some types of cancer increases after organ transplantation compared to general population and it is well documented in clinical... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Trastuzumab in metastatic breast cancer after complete remission: How long is enough?
by Oguz, Arzu and Rahatli, Samed and Altundag, Ozden and Altundag, Kadri
Medical Oncology, ISSN 1357-0560, 8/2015, Volume 32, Issue 8, pp. 1 - 2
Pathology | Oncology | Internal Medicine | Medicine & Public Health | Hematology | ONCOLOGY | Breast cancer | Metastasis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Triple negative breast cancer: Demographic and clinicopathological properties
by Yildiran Keskin, Gul Sema and Oguz, Arzu and Colak, Dilsen and Akcali, Zafer and Altundag, Ozden and Altundag, Mustafa Kadri
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. e12572 - e12572
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Combined versus sequential antracycline and taxane adjuvant regimens in triple negative breast cancer patients
by Oguz, Arzu and Yildiran Keskin, Gul Sema and Akcali, Zafer and Colak, Dilsen and Altundag, Ozden and Altundag, Mustafa Kadri
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. e12578 - e12578
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Treatment of lymph node-negative, early-stage HER2-positive breast cancer
by Oguz, Arzu and Keskin, Gul Sema and Colak, Dilsen and Altundag, Ozden and Akcali, Zafer
Journal of Clinical Oncology, ISSN 0732-183X, 02/2016, Volume 34, Issue 6, pp. 639 - 640
Breast Neoplasms - enzymology | Receptor, ErbB-2 - biosynthesis | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Female | Antineoplastic Agents - therapeutic use | Breast Neoplasms - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text The relationship between glucose metabolism disorders and malignant thyroid disease
by Duran, Ayse Ocak and Duran, Ayse Ocak and Anil, Cüneyd and Anil, Cüneyd and Gursoy, Alptekin and Gursoy, Alptekin and Nar, Aslı and Nar, Aslı and Altundag, Ozden and Altundag, Ozden and Tutuncu, Neslihan Bascil and Tutuncu, Neslihan Bascil
International Journal of Clinical Oncology, ISSN 1341-9625, 8/2013, Volume 18, Issue 4, pp. 585 - 589
Previous studies have shown a positive relationship between insulin resistance and several common adult cancers. The present retrospective study aimed to... 
Oncology | Cancer Research | Thyroid cancer | Medicine & Public Health | Glucose metabolism disorders | Surgical Oncology | DIABETES-MELLITUS | BREAST-CANCER | UNITED-STATES | ONCOLOGY | SERUM GLUCOSE | INSULIN-RESISTANCE | PANCREATIC-CANCER | RISK | COHORT | Multivariate Analysis | Humans | Middle Aged | Thyroid Nodule - diagnosis | Male | Thyroid Nodule - metabolism | Young Adult | Biopsy, Fine-Needle | Thyroid Nodule - pathology | Adolescent | Glucose Metabolism Disorders - metabolism | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Glucose Metabolism Disorders - pathology | Thyroid Neoplasms - metabolism | Thyroid Neoplasms - pathology | Thyrotropin - blood
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Two cases of sarcomas in the heart; one primary, one metastatic
by Yildiran Keskin, Gul Sema and Oguz, Arzu and Rahatli, Samed and Akcali, Zafer and Altundag, Ozden
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. e21510 - e21510
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Correlation of histopahologic response and prognostic markers with survival in locally advanced non-small cell lung cancer patients who have treated with neoadjuvant chemotherapy
by Kucukoztas, Nadire and Oguz, Arzu and Rahatli, Samed and Dizdar, Omer and Yildiran Keskin, Gul Sema and Ozyilkan, Ozgur and Altundag, Ozden
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. e18521 - e18521
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Oxaliplatin-induced immune thrombocytopenia in a patient with colon cancer
by Akdeniz, Aydan and Kucukoztas, Nadire and Yalcin, Selim and Akcali, Zafer and Altundag, Ozden
American Surgeon, ISSN 0003-1348, 01/2011, Volume 77, Issue 1, p. E9
  At the beginning of the 12th cycle, her hemoglobin was 12.1 g/dL, white blood cell count (WBC) was 4,500/mL, and platelet count was 151,000/ mL. [...]it is... 
Immunocompromised Host - immunology | Adenocarcinoma - pathology | Follow-Up Studies | Humans | Middle Aged | Colectomy - methods | Antineoplastic Agents - administration & dosage | Organoplatinum Compounds - administration & dosage | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Female | Chemotherapy, Adjuvant | Severity of Illness Index | Pyridines - administration & dosage | Risk Assessment | Thrombocytopenia - immunology | Thrombocytopenia - physiopathology | Thrombocytopenia - chemically induced | Withholding Treatment | Adenocarcinoma - drug therapy | Sigmoid Neoplasms - drug therapy | Sigmoid Neoplasms - surgery | Organoplatinum Compounds - adverse effects | Adenocarcinoma - surgery | Sigmoid Neoplasms - pathology | Chemotherapy | Blood platelets | Drug dosages | Medical treatment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Response rates of taxane rechallenge in metastatic breast cancer patients, previously treated with adjuvant taxanes
by Oguz, Arzu and Babacan, Taner and Dizdar, Omer and Kucukoztas, Nadire and Rahatli, Samed and Yildiran Keskin, Gul Sema and Altundag, Ozden and Altundag, Kadri
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. 1073 - 1073
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text The relationship between thyroid volume and malignant thyroid disease
by Duran, Ayse Ocak and Duran, Ayse Ocak and Anil, Cuneyd and Anil, Cuneyd and Gursoy, Alptekin and Gursoy, Alptekin and Nar, Aslı and Nar, Aslı and Altundag, Ozden and Altundag, Ozden and Inanc, Mevlude and Inanc, Mevlude and Bozkurt, Oktay and Bozkurt, Oktay and Tutuncu, Neslihan Bascil and Tutuncu, Neslihan Bascil
Medical Oncology, ISSN 1357-0560, 1/2014, Volume 31, Issue 1, pp. 1 - 4
The present retrospective study aimed to investigate the relationship between thyroid volume and prevalence of thyroid cancer. We investigated the data of... 
Pathology | Thyroid cancer | Medicine & Public Health | Hematology | Oncology | Internal Medicine | Thyroid volume | NODULES | FINE-NEEDLE-ASPIRATION | ONCOLOGY | PREDICTORS | SOLITARY | CANCER | Hypothyroidism | Thyrotropin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Posttransplant Malignancies in Adult Renal and Hepatic Transplant Patients
by Rahatli, Samed and Altundag, Ozden and Ayvazoglu Soy, Ebru and Moray, Gokhan and Haberal, Mehmet
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 08/2018
The risk of some cancer types increases after organ transplant compared with that shown in the general population; this has been well documented in clinical... 
Journal Article
Details down arrow
14. Full Text Is there any correlation between molecular subtypes and blood groups in breast cancer?
by Kucukoztas, Nadire and Oguz, Arzu and Babacan, Taner and Dizdar, Omer and Rahatli, Samed and Sarici, Saim Furkan and Yildiran Keskin, Gul Sema and Diker, Omer and Akin, Serkan and Altundag, Ozden and Altundag, Kadri
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. e11554 - e11554
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Trastuzumab in metastatic breast cancer after complete remission: How long is enough?
by Oguz, Arzu and Rahatli, Samed and Altundag, Ozden and Altundag, Kadri
Medical oncology (Northwood, London, England), 08/2015, Volume 32, Issue 8, p. 211
Disease-Free Survival | Trastuzumab - therapeutic use | Breast Neoplasms - pathology | Humans | Breast Neoplasms - mortality | Female | Receptor, ErbB-2 - antagonists & inhibitors | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text The preoperative albumin level is an independent prognostic factor for optimally debulked epithelial ovarian cancer
by Ayhan, Ali and Günakan, Emre and Alyazıcı, İrem and Haberal, Nihan and Altundağ, Özden and Dursun, Polat
Archives of Gynecology and Obstetrics, ISSN 0932-0067, 11/2017, Volume 296, Issue 5, pp. 989 - 995
A low albumin level has been reported to be a prognostic factor for various cancers. The aim of this study was to determine the association between... 
Obstetrics/Perinatology/Midwifery | Human Genetics | Optimal debulking | Medicine & Public Health | Gynecology | Preoperative albumin | Overall survival | Endocrinology | Ovarian cancer | SURVIVAL | CYTOREDUCTIVE SURGERY | PREDICTOR | METAANALYSIS | SERUM-ALBUMIN | SCORE GPS | ELDERLY-WOMEN | CHEMOTHERAPY | OBSTETRICS & GYNECOLOGY | MALNUTRITION | SEVERE POSTOPERATIVE COMPLICATIONS | Neoplasms, Glandular and Epithelial - pathology | Prognosis | Humans | Middle Aged | Kaplan-Meier Estimate | Ovarian Neoplasms - pathology | Ovarian Neoplasms - blood | Ovarian Neoplasms - mortality | Serum Albumin - analysis | Biomarkers, Tumor - blood | Neoplasms, Glandular and Epithelial - blood | Neoplasms, Glandular and Epithelial - mortality | Sensitivity and Specificity | Survival Analysis | Carcinoma, Ovarian Epithelial | Adult | Female | ROC Curve | Aged | Retrospective Studies | Ascites | Preoperative Period | Medical colleges | Oncology, Experimental | Analysis | Albumin | Research | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Response rates of taxane rechallenge in metastatic breast cancer patients previously treated with adjuvant taxanes
by Kucukoztas, Nadire and Oguz, Arzu and Rahatli, Samed and Altundag, Ozden and Altundag, Kadri
Journal of B.U.ON, ISSN 1107-0625, 09/2016, Volume 21, Issue 5, pp. 1076 - 1081
Purpose: This study was conducted to determine the efficacy of taxane-based regimens in patients with metastatic breast cancer pre-treated with taxanes in... 
Breast cancer | Taxanes | Rechallenge | Response rates | TRASTUZUMAB | taxanes | response rates | breast cancer | DOCETAXEL | PACLITAXEL | TRIAL | AGENT | RELAPSE | THERAPY | ONCOLOGY | RANDOMIZED PHASE-III | COMBINATION CHEMOTHERAPY | rechallenge | Humans | Middle Aged | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Treatment Outcome | Breast Neoplasms - drug therapy | Young Adult | Disease-Free Survival | Retreatment | Taxoids - therapeutic use | Neoplasm Metastasis | Turkey | Time Factors | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Adult | Breast Neoplasms - mortality | Female | Neoadjuvant Therapy | Aged | Retrospective Studies | Chemotherapy, Adjuvant
Journal Article
Details down arrow
18. Effect of increased number of neoadjuvant chemotherapy cycles on tumor resectability and pathologic response in advanced stage epithelial ovarian cancer
by Akilli, Huseyin and Rahatli, Samed and Tohma, Yusuf Aytac and Karakas, Latife Atasoy and Altundag, Ozden and Ayhan, Ali
Journal of B.U.ON, ISSN 1107-0625, 2018, Volume 23, Issue 7, pp. 111 - 115
Purpose: To identify the significance of the number of neoadjuvant chemotherapy (NACT) cycles on pathologic response and to define relationship between... 
Neoadjuvant chemotherapy | Epithelial ovarian cancer | Interval debulking surgery | SURVIVAL | neoadjuvant chemotherapy | CELLS | IMPACT | CYTOREDUCTIVE SURGERY | ONCOLOGY | RESISTANCE | PRIMARY DEBULKING SURGERY | epithelial ovarian cancer | interval debulking surgery | Prognosis | Follow-Up Studies | Humans | Middle Aged | Carcinoma, Ovarian Epithelial - surgery | Carboplatin - administration & dosage | Survival Rate | Cystadenocarcinoma, Serous - pathology | Cystadenocarcinoma, Serous - drug therapy | Case-Control Studies | Cystadenocarcinoma, Serous - surgery | Preoperative Care | Neoadjuvant Therapy - mortality | Carcinoma, Ovarian Epithelial - pathology | Carcinoma, Ovarian Epithelial - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Paclitaxel - administration & dosage
Journal Article
Details down arrow
19. Full Text Effect of surgical staging on 539 patients with borderline ovarian tumors: A Turkish Gynecologic Oncology Group study
by Guvenal, Tevfik and Dursun, Polat and Hasdemir, Pinar S and Hanhan, Merih and Guven, Suleyman and Yetimalar, Hakan and Goksedef, Behice P and Sakarya, Derya K and Doruk, Arzu and Terek, Mustafa C and Saatli, Bahadir and Guzin, Kadir and Corakci, Aydin and Deger, Emek and Celik, Husnu and Cetin, Ahmet and Ozsaran, Aydin and Ozbakkaloglu, Ayşe and Kolusari, Ali and Celik, Cetin and Keles, Refik and Sagir, Fulya G and Dilek, Saffet and Uslu, Turhan and Dikmen, Yilmaz and Altundag, Ozden and Ayhan, Ali
Gynecologic Oncology, ISSN 0090-8258, 2013, Volume 131, Issue 3, pp. 546 - 550
Abstract Objective The objectives of this study were to examine demographic and clinicopathologic characteristics and to determine the effects of primary... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Lymphadenectomy | Appendectomy | Borderline | Surgical staging | Ovarian tumor | RISK-FACTORS | MANAGEMENT | CONSERVATIVE SURGERY | ACCURACY | OBSTETRICS & GYNECOLOGY | FROZEN-SECTION DIAGNOSIS | ONCOLOGY | RECURRENCE | Lymph Node Excision | Lymph Nodes - pathology | Lymph Nodes - surgery | Humans | Middle Aged | Kaplan-Meier Estimate | Ovarian Neoplasms - pathology | Lymphatic Metastasis | Ovarian Neoplasms - epidemiology | Neoplasm Recurrence, Local - pathology | Young Adult | Turkey - epidemiology | Adolescent | Aged, 80 and over | Adult | Female | Aged | Neoplasm Recurrence, Local - epidemiology | Retrospective Studies | Neoplasm Staging | Ovarian Neoplasms - surgery | Medicine, Experimental | Medical research | Ovarian cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Tiroid kanserinde tirozin kinaz inhibitörleri: Axl/Gas6 yolaǧi{dotless} gizli bir hedef olabilir mi?
by Isildak, S. Mehlika and Tutuncu, Neslihan B and Altundag, Ozden
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, ISSN 1306-133X, 2013, Volume 23, Issue 3, pp. 207 - 212
Thyroid cancer | Axl/gas6 signalling | Tyrosine kinase inhibitor
Journal Article
Details down arrow
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.